Case study demonstrates progression from oral lichen planus to XLP-1 diagnosis through genetic testing, highlighting immune disorders.
A 14‐year‐old boy was initially diagnosed with erosive oral lichen planus based on clinical and histopathological findings. However, the atypical clinical course and resistance to immunosuppressive therapy raised suspicion for an autoinflammatory disorder or inborn error of immunity. Genetic testing revealed a pathogenic SH2D1A mutation, confirming X‐linked lymphoproliferative disease type 1 (XLP‐1) in the absence of Epstein‐Barr virus exposure. This case highlights oral mucosal lesions as a potential early, EBV‐independent manifestation of XLP‐1 and emphasizes the importance of considering monogenic immune disorders in persistent, treatment‐refractory mucosal disease.
No takes yet. Share an insight, caveat, or question.
Brufau‐Cochs et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: